Trump Tariffs Unlikely to Hurt Indian Pharma Companies: Morgan Stanley
Morgan Stanley says Trump’s plan to impose 100% tariffs on imported branded and patented pharmaceuticals may not significantly impact Indian companies, except for those with specialty drug exposure like Sun Pharma.